Blood test monitoring for stage 4 colorectal cancer after surgery
Part of Cancer, Digestive system clinical trials.
This study tests if a simple blood test can help watch for cancer returning after surgery in people with colorectal cancer that has spread to other organs. It aims to improve follow-up care and help you feel more in control of your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with colorectal cancer that has spread to other parts of the body (stage 4).
- You have not yet had surgery to remove the cancer, and you have not received chemotherapy, radiation, or other cancer treatments.
- Doctors believe it is possible to surgically remove all cancer, both in the colon and any spread areas.
- You are in good overall health, able to care for yourself (Eastern Cooperative Oncology Group score of 0 or 1).
- You are willing to commit to regular follow-up visits at the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test (called MRD) after surgery to see if any tiny bits of cancer DNA are left. It helps doctors decide whether extra chemotherapy is needed or if it can be safely skipped, and it may reduce unnecessary side effects.
This study is looking at whether regular checks of your blood for tiny pieces of cancer DNA (called MRD) can help doctors monitor for the cancer coming back after surgery. It plans to use this information to guide follow-up care.
This study looks at a blood “DNA” test to see if it can help monitor colorectal cancer after surgery. It may benefit you by improving how doctors track cancer during routine follow-up visits.
This study measures “minimal residual disease,” meaning tiny amounts of cancer that may remain after surgery, using blood samples. It may help doctors better detect who is at higher risk of cancer coming back and guide follow-up care.
This trial uses a simple blood test to look for tiny bits of tumor DNA after colon cancer surgery. If found, it may help doctors catch any remaining cancer early and guide further treatment.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.